Nib Holdings Sells Travel Insurance Operations for $117.5M to Refocus on Health
nib Holdings has concluded its strategic review of travel insurance operations by selling its Australian and New Zealand travel business to Allianz Partners for up to $50 million AUD. The transaction follows the earlier divestment of World Nomads to SiriusPoint for $67.5 million AUD, announced in February 2026.
The sale comprises $30 million receivable on completion and $20 million subject to conditions being met over the first 12 months following completion. The transaction is expected to complete by the end of 2026, subject to regulatory approval and standard completion requirements.
What’s included in the Allianz Partners transaction
The Allianz Partners acquisition encompasses:
- Australian and New Zealand travel insurance portfolio
- Partnerships and white label distribution channel
- Travel Insurance Direct (TID) brand
World Nomads is not part of this transaction, having been sold separately to International Medical Group, a wholly-owned subsidiary of SiriusPoint. Allianz Partners is a wholly-owned subsidiary of Allianz Group, operating as a global leader in insurance and assistance services across 73 markets with 22,200 employees.
When big ASX news breaks, our subscribers know first
Strategic partnership secures ongoing revenue stream
Alongside the divestment, nib and Allianz Partners have entered a long-term distribution agreement. Under this arrangement, nib will distribute nib-branded travel insurance products to its customers in Australia and New Zealand through its own channels, receiving ongoing upfront commissions for this distribution. Importantly, commissions from this distribution agreement are additional to the $50 million sale price and represent an ongoing revenue stream for nib.
Ed Close, Managing Director and Chief Executive Officer
“Travel insurance remains highly valued to our customers, and this long-term agreement ensures continued access, while enabling us to stay focused on health and related services.”
The partnership converts nib’s capital-intensive insurance underwriting operation into a capital-light distribution model, allowing the company to maintain its customer offering whilst redeploying capital toward core health services.
Understanding insurance portfolio simplification
Diversified insurers divest non-core segments to improve capital allocation efficiency, sharpen management focus, and reduce regulatory complexity. Health insurance and travel insurance operate as distinct businesses with different risk profiles, distribution requirements, and operational frameworks.
In FY25, nib Travel contributed $6.7 million to Group underlying operating profit against total Group UOP of $239.2 million, representing approximately 2.8% of earnings. The relatively modest earnings contribution explains management’s strategic decision to exit the segment entirely rather than pursue organic growth.
Travel insurance requires separate underwriting expertise, claims management infrastructure, and regulatory oversight compared to health insurance. By exiting the segment, nib simplifies its operational footprint whilst retaining customer-facing distribution economics through the Allianz Partners partnership.
Transaction timeline and capital management
Both travel insurance divestments are on track to complete during 2026. The sale consideration for both the SiriusPoint and Allianz Partners transactions is expected to be materially in line with the carrying value of the assets at completion. nib has stated it will undertake a capital management review to determine the most effective use of proceeds from the sales.
The World Nomads sale to SiriusPoint, announced in February 2026 for $67.5 million AUD, marked the first leg of nib’s two-part travel exit, with the AU/NZ business now following to Allianz Partners to complete the full portfolio simplification.
| Transaction | Buyer | Consideration | Status |
|---|---|---|---|
| World Nomads | SiriusPoint (via IMG) | $67.5m AUD | On track for 2026 completion |
| AU/NZ Travel (TID, partnerships, white label) | Allianz Partners | Up to $50m AUD | Expected end of 2026 |
The next major ASX story will hit our subscribers first
nib’s refocused investment thesis
Ed Close, Managing Director and Chief Executive Officer
“This transition simplifies our portfolio and allows us to focus our capital and capability where we see the strongest long-term value.”
The strategic review announced in May 2025 has led to the orderly divestment of all three travel insurance brands operated by nib. Jarden and Ashurst advised nib on the transaction.
The strategic review outcome comprises three distinct elements:
- World Nomads sold to SiriusPoint for $67.5 million
- AU/NZ travel business sold to Allianz Partners for up to $50 million
- Long-term distribution partnership retains nib-branded travel products for customers
nib emerges from the portfolio simplification as a more focused health insurer with streamlined operations concentrated on its core health insurance business and broader health services strategy. The combined proceeds of approximately $117.5 million provide capital optionality for shareholder returns or investment in health-adjacent services that align with management’s stated strategic priorities.
nib’s core health insurance margins face their own structural pressure, with claims payments surging 9% to $2.3 billion in FY25 against a 5.47% approved premium increase, making capital redeployment from the travel divestments a meaningful lever for the group.
Both parties have committed to a smooth transition period, ensuring customers, travellers, and nib partners continue to receive service and support during the handover to Allianz Partners.
Don’t Miss the Next Insurance or Finance Breakout
Join 20,000+ investors getting FREE breaking ASX news delivered to your inbox within minutes, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to start receiving alerts the moment market-moving announcements drop across finance, insurance, and every non-resource sector.